{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:55:19Z","timestamp":1760853319967},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.neuroscience.2007.11.044","type":"journal-article","created":{"date-parts":[[2007,12,10]],"date-time":"2007-12-10T15:06:02Z","timestamp":1197299162000},"page":"734-740","source":"Crossref","is-referenced-by-count":26,"title":["Cortical expression of brain derived neurotrophic factor and type-1 cannabinoid receptor after striatal excitotoxic lesions"],"prefix":"10.1016","volume":"152","author":[{"given":"Z.","family":"De March","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Zuccato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Giamp\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Patassini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Gasperi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"De Ceballos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Maccarrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.R.","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2007.11.044_bib1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ana.410270403","article-title":"Striatal and nigral neuron subpopulations in rigid Huntington\u2019s disease: implications for the functional anatomy of chorea and rigidity-akinesia","volume":"27","author":"Albin","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib2","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJM199005033221807","article-title":"Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington\u2019s disease","volume":"322","author":"Albin","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410310412","article-title":"Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington\u2019s disease","volume":"31","author":"Albin","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib4","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","article-title":"Anterograde transport of brain-derived neurotrophic factor and its role in the brain","volume":"389","author":"Altar","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib5","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","article-title":"Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor","volume":"24","author":"Baquet","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib6","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.4049\/jimmunol.177.8.4971","article-title":"Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells","volume":"177","author":"Bari","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib7","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1210\/en.2004-1154","article-title":"Corticotropin-releasing hormone-mediated induction of intracellular signaling pathways and brain-derived neurotrophic factor expression is inhibited by the activation of the endocannabinoid system","volume":"146","author":"Bayatti","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib8","doi-asserted-by":"crossref","first-page":"19115","DOI":"10.1073\/pnas.0509494102","article-title":"Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor","volume":"102","author":"Berghuis","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuint.2007.06.031","article-title":"Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6\/2 mice, a transgenic model of Huntington\u2019s disease","volume":"52","author":"Bisogno","year":"2008","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib10","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1471-4159.2005.03074.x","article-title":"In vivo up-regulation of brain-derived neurotrophic factor in specific brain areas by chronic exposure to delta-tetrahydrocannabinol","volume":"93","author":"Butovsky","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib11","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington\u2019s disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.tips.2007.02.004","article-title":"The endocannabinoid system in targeting inflammatory neurodegenerative diseases","volume":"28","author":"Centonze","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib13","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1523\/JNEUROSCI.17-07-02295.1997","article-title":"Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport","volume":"17","author":"Conner","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1006\/nbdi.1998.0220","article-title":"Brain cannabinoid systems as targets for the therapy of neurological disorders","volume":"5","author":"Consroe","year":"1998","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00005072-198809000-00003","article-title":"Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington\u2019s disease","volume":"47","author":"de la Monte","year":"1988","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0306-4522(00)00157-3","article-title":"Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington\u2019s disease mice","volume":"98","author":"Denovan-Wright","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib17","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1523\/JNEUROSCI.23-06-02371.2003","article-title":"Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus","volume":"23","author":"Derkinderen","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/exnr.1994.1145","article-title":"Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats","volume":"129","author":"Figueredo-Cardenas","year":"1994","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib19","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1523\/JNEUROSCI.19-04-01189.1999","article-title":"Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington\u2019s disease","volume":"19","author":"Fusco","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib20","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1460-9568.2003.02844.x","article-title":"Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain","volume":"18","author":"Fusco","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/syn.20047","article-title":"Immunolocalization of CB1 receptor in rat striatal neurons: a confocal microscopy study","volume":"53","author":"Fusco","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington\u2019s disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington\u2019s disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1073858406296716","article-title":"Endocannabinoids and synaptic function in the CNS","volume":"13","author":"Hashimotodani","year":"2007","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib24","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/j.1460-9568.2004.03285.x","article-title":"Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity","volume":"19","author":"Khaspekov","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib27","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1097\/00001756-200107200-00017","article-title":"Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington\u2019s disease","volume":"12","author":"Lastres-Becker","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0006-8993(01)03403-5","article-title":"Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington\u2019s disease","volume":"929","author":"Lastres-Becker","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib29","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/00001756-200305060-00007","article-title":"Effects of cannabinoids in the rat model of Huntington\u2019s disease generated by an intrastriatal injection of malonate","volume":"14","author":"Lastres-Becker","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib30","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.1471-4159.2003.01595.x","article-title":"Compounds acting at the endocannabinoid and\/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington\u2019s disease","volume":"84","author":"Lastres-Becker","year":"2003","journal-title":"J Neurochem"},{"issue":"168","key":"10.1016\/j.neuroscience.2007.11.044_bib31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/3-540-26573-2_18","article-title":"Effects of cannabinoids on hypothalamic and reproductive function","author":"Maccarrone","year":"2005","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pneurobio.2006.11.006","article-title":"The endocannabinoid pathway in Huntington\u2019s disease: a comparison with other neurodegenerative diseases","volume":"81","author":"Maccarrone","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib33","doi-asserted-by":"crossref","first-page":"E298","DOI":"10.1208\/aapsj080234","article-title":"Cannabinoid receptors and endocannabinoids: evidence for new players","volume":"8","author":"Mackie","year":"2006","journal-title":"AAPS J"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib34","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1111\/j.1460-9568.2007.05565.x","volume":"25","author":"Maj","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib37","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1523\/JNEUROSCI.22-22-09771.2002","article-title":"Increased severity of stroke in CB1 cannabinoid receptor knock-out mice","volume":"22","author":"Parmentier-Batteur","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1054\/plef.2001.0341","article-title":"Cannabinoid receptors and their ligands","volume":"66","author":"Pertwee","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib39","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1006\/nbdi.1998.0221","article-title":"Endogenous cannabinoid signaling","volume":"5","author":"Piomelli","year":"1998","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib41","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib42","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","article-title":"Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis","volume":"60","author":"Rosas","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib44","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib45","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/01688638708405354","article-title":"Memory failure in Huntington\u2019s disease","volume":"9","author":"Wilson","year":"1987","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib47","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.neuroscience.2007.11.044_bib49","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington\u2019s disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog Neurobiol"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452207015291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452207015291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T17:00:40Z","timestamp":1557075640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452207015291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0306452207015291"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2007.11.044","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}